Platelet Aggregation Inhibitor [EPC]

Platelet Aggregation Inhibitor [EPC] was reported 571580 times

Drugs of the Platelet Aggregation Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 363 0.3418
1 NEPHROGENIC ANAEMIA 1522 0.3282
2 HYPERPARATHYROIDISM SECONDARY 791 0.3154
3 VASCULAR STENT THROMBOSIS 632 0.3103
4 ESSENTIAL HYPERTENSION 478 0.2609
5 DIVERTICULUM INTESTINAL HAEMORRHAGIC 509 0.2262
6 CORONARY ARTERY STENOSIS 1082 0.2149
7 ANGINA UNSTABLE 1383 0.2126
8 REBOUND ACID HYPERSECRETION 643 0.2124
9 HAEMORRHAGIC ANAEMIA 931 0.2116
10 SEDATION COMPLICATION 529 0.2071
11 LOWER GASTROINTESTINAL HAEMORRHAGE 1507 0.2036
12 CAROTID ARTERY STENOSIS 710 0.2031
13 THROMBOSIS IN DEVICE 662 0.2018
14 CORONARY ARTERY DISEASE 5979 0.1972
15 ISCHAEMIC CARDIOMYOPATHY 602 0.1962
16 UPPER GASTROINTESTINAL HAEMORRHAGE 3283 0.1950
17 CORONARY ARTERIAL STENT INSERTION 917 0.1807
18 DIASTOLIC DYSFUNCTION 553 0.1790
19 CREATININE RENAL CLEARANCE DECREASED 705 0.1760
20 CORONARY ARTERY OCCLUSION 2415 0.1759
21 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1523 0.1721
22 RETROPERITONEAL HAEMORRHAGE 421 0.1704
23 GASTROINTESTINAL HAEMORRHAGE 13993 0.1673
24 ACUTE MYOCARDIAL INFARCTION 4853 0.1644
25 DUODENAL ULCER HAEMORRHAGE 469 0.1638
26 GASTRIC ULCER HAEMORRHAGE 893 0.1610
27 BLOOD LOSS ANAEMIA 359 0.1584
28 END STAGE RENAL DISEASE 2754 0.1508
29 CAROTID ARTERY OCCLUSION 550 0.1506
30 CORONARY ARTERY BYPASS 866 0.1505
31 ARTERIOSCLEROSIS CORONARY ARTERY 986 0.1487
32 VENTRICULAR HYPERTROPHY 368 0.1466
33 ORTHOPNOEA 464 0.1455
34 ULCER HAEMORRHAGE 979 0.1445
35 HAEMORRHAGIC STROKE 1125 0.1439
36 MITRAL VALVE INCOMPETENCE 1622 0.1432
37 RADICULOPATHY 374 0.1418
38 BRAIN NATRIURETIC PEPTIDE INCREASED 431 0.1397
39 AORTIC STENOSIS 482 0.1383
40 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 561 0.1373
41 BENIGN PROSTATIC HYPERPLASIA 702 0.1358
42 THERAPEUTIC AGENT TOXICITY 452 0.1354
43 GASTRITIS EROSIVE 630 0.1350
44 ARTERIAL OCCLUSIVE DISEASE 1061 0.1349
45 LEFT VENTRICULAR HYPERTROPHY 577 0.1347
46 ANGINA PECTORIS 3840 0.1339
47 LEFT VENTRICULAR FAILURE 451 0.1309
48 MYOCARDIAL ISCHAEMIA 1486 0.1304
49 DUODENAL ULCER 921 0.1304
50 PERIPHERAL VASCULAR DISORDER 671 0.1301
51 HYPERLIPIDAEMIA 1547 0.1293
52 MULTIPLE INJURIES 803 0.1274
53 RENAL FAILURE CHRONIC 975 0.1267
54 TRICUSPID VALVE INCOMPETENCE 1006 0.1265
55 BUNDLE BRANCH BLOCK LEFT 528 0.1244
56 AORTIC VALVE INCOMPETENCE 528 0.1240
57 DUODENITIS 377 0.1228
58 HIGH DENSITY LIPOPROTEIN DECREASED 404 0.1212
59 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3547 0.1210
60 MELAENA 2659 0.1207
61 VENTRICULAR HYPOKINESIA 387 0.1204
62 DIVERTICULUM 852 0.1198
63 NON-CARDIAC CHEST PAIN 379 0.1197
64 ARTERIOSCLEROSIS 1127 0.1196
65 FLUSHING 11879 0.1167
66 ACUTE CORONARY SYNDROME 965 0.1164
67 GASTRIC HAEMORRHAGE 1335 0.1159
68 TRANSIENT ISCHAEMIC ATTACK 3838 0.1136
69 DIABETIC NEUROPATHY 562 0.1134
70 CHRONIC KIDNEY DISEASE 8469 0.1113
71 HAEMORRHAGE INTRACRANIAL 1653 0.1104
72 CARDIAC MURMUR 951 0.1098
73 DIVERTICULUM INTESTINAL 467 0.1067
74 SUPRAVENTRICULAR EXTRASYSTOLES 357 0.1056
75 BREATH SOUNDS ABNORMAL 520 0.1053
76 ATRIOVENTRICULAR BLOCK FIRST DEGREE 457 0.1053
77 HAEMORRHOIDAL HAEMORRHAGE 514 0.1052
78 GASTRIC ULCER 1996 0.1049
79 SUBARACHNOID HAEMORRHAGE 1063 0.1043
80 STENT PLACEMENT 841 0.1042
81 CARDIAC FAILURE CONGESTIVE 8318 0.1034
82 SUBDURAL HAEMATOMA 1474 0.1029
83 CHRONIC SINUSITIS 386 0.1027
84 HYPOVOLAEMIA 598 0.1021
85 SHOCK HAEMORRHAGIC 831 0.1020
86 DYSLIPIDAEMIA 518 0.1019
87 ECCHYMOSIS 699 0.1019
88 IRON DEFICIENCY ANAEMIA 939 0.1016
89 ATRIAL FLUTTER 803 0.1005
90 ORTHOSTATIC HYPOTENSION 1751 0.1005
91 BLOOD CALCIUM DECREASED 1129 0.1003
92 RENAL FAILURE ACUTE 4253 0.1001
93 VITAMIN B12 DEFICIENCY 402 0.0992
94 HAEMATURIA 3395 0.0990
95 RALES 575 0.0989
96 ATELECTASIS 955 0.0987
97 LEFT VENTRICULAR DYSFUNCTION 661 0.0986
98 CARDIOMEGALY 1203 0.0977
99 RENAL CYST 771 0.0970
100 RECTAL HAEMORRHAGE 4168 0.0969
101 HEMIPLEGIA 805 0.0967
102 BUNDLE BRANCH BLOCK RIGHT 442 0.0962
103 BRONCHIECTASIS 647 0.0959
104 VENTRICULAR EXTRASYSTOLES 995 0.0957
105 HAEMATEMESIS 2426 0.0956
106 TROPONIN INCREASED 728 0.0956
107 SPINAL OSTEOARTHRITIS 840 0.0955
108 BLOOD PRESSURE DIASTOLIC DECREASED 701 0.0949
109 INTERNAL HAEMORRHAGE 1080 0.0944
110 DYSPNOEA EXERTIONAL 3553 0.0942
111 BLOOD UREA INCREASED 1578 0.0941
112 CATHETERISATION CARDIAC 416 0.0937
113 SPINAL COLUMN STENOSIS 440 0.0931
114 HAEMATOCRIT DECREASED 1833 0.0923
115 HIATUS HERNIA 1192 0.0920
116 INCREASED TENDENCY TO BRUISE 844 0.0916
117 ANGIOPATHY 510 0.0909
118 CARDIAC FAILURE CHRONIC 386 0.0905
119 ELECTROCARDIOGRAM ABNORMAL 709 0.0903
120 CEREBRAL HAEMORRHAGE 3226 0.0900
121 MYOCARDIAL INFARCTION 15650 0.0896
122 HAEMATOMA 2319 0.0894
123 VENTRICULAR TACHYCARDIA 1461 0.0884
124 SINUS BRADYCARDIA 855 0.0884
125 URINARY TRACT DISORDER 397 0.0881
126 INTERNATIONAL NORMALISED RATIO DECREASED 355 0.0876
127 BODY HEIGHT DECREASED 937 0.0875
128 AORTIC ANEURYSM 665 0.0873
129 HYPERCHOLESTEROLAEMIA 837 0.0866
130 ATRIAL FIBRILLATION 8440 0.0866
131 GOUT 1554 0.0865
132 EXERCISE TOLERANCE DECREASED 497 0.0863
133 SLEEP APNOEA SYNDROME 1639 0.0858
134 ISCHAEMIA 394 0.0856
135 CEREBRAL ISCHAEMIA 438 0.0850
136 VENTRICULAR FIBRILLATION 942 0.0847
137 SEASONAL ALLERGY 1197 0.0845
138 BLOOD PRESSURE SYSTOLIC INCREASED 1649 0.0845
139 FULL BLOOD COUNT ABNORMAL 892 0.0843
140 NOCTURIA 1017 0.0837
141 CARDIAC VALVE DISEASE 477 0.0834
142 GANGRENE 502 0.0832
143 MYOPATHY 714 0.0826
144 INTERVERTEBRAL DISC DEGENERATION 759 0.0819
145 FAECES DISCOLOURED 1777 0.0819
146 HEMIPARESIS 1386 0.0817
147 RHINITIS ALLERGIC 364 0.0817
148 HAEMOPTYSIS 2270 0.0813
149 BLOOD PRESSURE SYSTOLIC DECREASED 369 0.0810
150 RHABDOMYOLYSIS 3380 0.0810
151 ATRIOVENTRICULAR BLOCK COMPLETE 542 0.0809
152 HEPARIN-INDUCED THROMBOCYTOPENIA 398 0.0807
153 COAGULOPATHY 1334 0.0800
154 HYPOVOLAEMIC SHOCK 383 0.0799
155 ATRIOVENTRICULAR BLOCK 618 0.0799
156 EPISTAXIS 5974 0.0798
157 PROTHROMBIN TIME PROLONGED 476 0.0795
158 OBSTRUCTIVE AIRWAYS DISORDER 884 0.0794
159 RENAL FUNCTION TEST ABNORMAL 367 0.0790
160 ISCHAEMIC STROKE 1410 0.0789
161 MACULAR DEGENERATION 942 0.0788
162 ANEURYSM 391 0.0785
163 CARDIAC TAMPONADE 371 0.0780
164 RENAL INJURY 2314 0.0778
165 POST PROCEDURAL HAEMORRHAGE 906 0.0777
166 HYPERKALAEMIA 2714 0.0773
167 ACUTE KIDNEY INJURY 11820 0.0772
168 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4007 0.0767
169 GASTRITIS 2018 0.0766
170 EJECTION FRACTION DECREASED 1188 0.0764
171 RENAL TUBULAR NECROSIS 743 0.0757
172 ACUTE RESPIRATORY FAILURE 1449 0.0752
173 CARDIAC FAILURE ACUTE 501 0.0751
174 FULL BLOOD COUNT DECREASED 1515 0.0751
175 INTERNATIONAL NORMALISED RATIO INCREASED 2139 0.0749
176 UROSEPSIS 691 0.0748
177 DIZZINESS POSTURAL 722 0.0744
178 LOW BIRTH WEIGHT BABY 590 0.0742
179 TUBULOINTERSTITIAL NEPHRITIS 1390 0.0741
180 HYPOMAGNESAEMIA 1032 0.0740
181 SUPRAVENTRICULAR TACHYCARDIA 707 0.0738
182 EXOSTOSIS 670 0.0733
183 RENAL FAILURE 9740 0.0733
184 CARDIOGENIC SHOCK 1051 0.0732
185 BLOOD POTASSIUM INCREASED 1185 0.0729
186 BLOOD PRESSURE INADEQUATELY CONTROLLED 436 0.0724
187 HAEMOGLOBIN DECREASED 7364 0.0716
188 SENSORY LOSS 577 0.0716
189 BLOOD MAGNESIUM DECREASED 618 0.0715
190 CARDIOMYOPATHY 1050 0.0710
191 HEART RATE IRREGULAR 1603 0.0709
192 CARDIAC PACEMAKER INSERTION 422 0.0707
193 MULTIPLE ALLERGIES 554 0.0706
194 PLATELET COUNT INCREASED 919 0.0704
195 VITAMIN D DEFICIENCY 685 0.0702
196 FEELING HOT 4302 0.0701
197 PULMONARY HYPERTENSION 1458 0.0699
198 RHINITIS 564 0.0699
199 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 354 0.0699
200 CHEST PAIN 12948 0.0698
201 PULMONARY ALVEOLAR HAEMORRHAGE 392 0.0698
202 NEPHROPATHY 649 0.0694
203 STOMACH DISCOMFORT 359 0.0694
204 CEREBROVASCULAR ACCIDENT 11756 0.0693
205 BLOOD URIC ACID INCREASED 397 0.0687
206 LOW DENSITY LIPOPROTEIN INCREASED 532 0.0687
207 SQUAMOUS CELL CARCINOMA OF SKIN 414 0.0685
208 ULCER 1088 0.0683
209 CONTUSION 6582 0.0683
210 FLANK PAIN 638 0.0680
211 COLITIS ISCHAEMIC 458 0.0678
212 HAEMATOCHEZIA 3739 0.0677
213 OEDEMA PERIPHERAL 8243 0.0676
214 COORDINATION ABNORMAL 943 0.0675
215 HEART RATE DECREASED 2373 0.0675
216 GROIN PAIN 591 0.0672
217 OESOPHAGITIS 733 0.0670
218 ABNORMAL LOSS OF WEIGHT 456 0.0668
219 PRESYNCOPE 1622 0.0666
220 ECONOMIC PROBLEM 1011 0.0666
221 BLOOD URINE PRESENT 1266 0.0666
222 GLOMERULAR FILTRATION RATE DECREASED 819 0.0666
223 EXTRASYSTOLES 465 0.0665
224 GASTROOESOPHAGEAL REFLUX DISEASE 5362 0.0665
225 CEREBRAL INFARCTION 1625 0.0664
226 GLUCOSE TOLERANCE IMPAIRED 393 0.0664
227 MICTURITION URGENCY 757 0.0662
228 BLOOD SODIUM DECREASED 1239 0.0657
229 ANAEMIA 12501 0.0655
230 BRADYCARDIA 3456 0.0651
231 BLOOD CREATININE INCREASED 4254 0.0651
232 MYOSITIS 584 0.0650
233 POLYP 426 0.0650
234 SYNCOPE 6499 0.0649
235 OSTEOARTHRITIS 2745 0.0647
236 BLOOD IRON DECREASED 759 0.0639
237 SINUS DISORDER 1266 0.0639
238 LUNG INFILTRATION 564 0.0638
239 PRODUCTIVE COUGH 3037 0.0636
240 GINGIVAL PAIN 505 0.0634
241 EMPHYSEMA 639 0.0633
242 INFUSION SITE SWELLING 398 0.0632
243 OEDEMA 3419 0.0630
244 MOUTH HAEMORRHAGE 462 0.0630
245 BLOOD POTASSIUM DECREASED 1894 0.0629
246 LARGE INTESTINE POLYP 436 0.0629
247 BLOOD CREATINE PHOSPHOKINASE INCREASED 1796 0.0623
248 BLOOD PRESSURE FLUCTUATION 1496 0.0623
249 RED BLOOD CELL COUNT DECREASED 1778 0.0621
250 ELECTROLYTE IMBALANCE 722 0.0621
251 PERICARDIAL EFFUSION 1436 0.0620
252 LACERATION 583 0.0619
253 INFUSION SITE ERYTHEMA 522 0.0619
254 SKIN LACERATION 673 0.0618
255 HAEMORRHOIDS 1207 0.0618
256 WALKING AID USER 407 0.0617
257 HYPOTENSION 12252 0.0610
258 DIABETES MELLITUS INADEQUATE CONTROL 1081 0.0610
259 RESPIRATORY TRACT INFECTION 1586 0.0608
260 BLOOD CHOLESTEROL INCREASED 2838 0.0608
261 RIB FRACTURE 1250 0.0607
262 SINUS CONGESTION 821 0.0607
263 FALL 20217 0.0607
264 WHEEZING 3600 0.0606
265 MUSCULOSKELETAL CHEST PAIN 938 0.0605
266 BALANCE DISORDER 5237 0.0605
267 ROTATOR CUFF SYNDROME 778 0.0605
268 BLOOD TRIGLYCERIDES INCREASED 1070 0.0605
269 URINE ODOUR ABNORMAL 356 0.0605
270 URINE OUTPUT DECREASED 529 0.0605
271 MENTAL STATUS CHANGES 1677 0.0603
272 BASAL CELL CARCINOMA 940 0.0602
273 EYE HAEMORRHAGE 803 0.0601
274 PULMONARY OEDEMA 2686 0.0599
275 CIRCULATORY COLLAPSE 1021 0.0599
276 PULMONARY CONGESTION 785 0.0595
277 HYPOGLYCAEMIA 2886 0.0594
278 CATARACT 3539 0.0594
279 PERIPHERAL COLDNESS 816 0.0594
280 BODY TEMPERATURE DECREASED 585 0.0594
281 DYSARTHRIA 2236 0.0593
282 INGUINAL HERNIA 360 0.0591
283 LEUKOCYTOSIS 1070 0.0591
284 FOETAL GROWTH RESTRICTION 359 0.0590
285 SCIATICA 939 0.0588
286 HAEMORRHAGE 6154 0.0588
287 HAEMODIALYSIS 494 0.0588
288 PRE-EXISTING CONDITION IMPROVED 366 0.0586
289 DIVERTICULITIS 1621 0.0584
290 TENDERNESS 607 0.0582
291 TYPE 2 DIABETES MELLITUS 1958 0.0581
292 BURSITIS 704 0.0580
293 BLOOD ALBUMIN DECREASED 460 0.0579
294 CARDIAC FLUTTER 374 0.0578
295 CARDIAC OPERATION 497 0.0578
296 BLOOD PRESSURE DECREASED 3841 0.0577
297 ANOREXIA 744 0.0577
298 HYPONATRAEMIA 3244 0.0575
299 DECUBITUS ULCER 467 0.0573
300 PROSTATIC SPECIFIC ANTIGEN INCREASED 789 0.0572
301 MOTOR DYSFUNCTION 583 0.0572
302 DEHYDRATION 7628 0.0571
303 PULMONARY MASS 851 0.0571
304 VASCULITIS 665 0.0570
305 MUSCULAR WEAKNESS 6478 0.0569
306 MUSCLE STRAIN 493 0.0569
307 MUSCULOSKELETAL DISCOMFORT 980 0.0569
308 CARPAL TUNNEL SYNDROME 797 0.0569
309 OSTEOPENIA 863 0.0568
310 CYSTITIS 1807 0.0567
311 CARDIAC FAILURE 4555 0.0567
312 CLOSTRIDIUM DIFFICILE COLITIS 601 0.0566
313 PULMONARY HAEMORRHAGE 443 0.0566
314 BLOOD ALKALINE PHOSPHATASE INCREASED 1406 0.0566
315 POSTOPERATIVE WOUND INFECTION 382 0.0565
316 VITAMIN D DECREASED 483 0.0564
317 CONSTIPATION 12306 0.0564
318 PLEURAL EFFUSION 3430 0.0563
319 SKIN HAEMORRHAGE 835 0.0563
320 GINGIVAL BLEEDING 769 0.0563
321 BLOOD PRESSURE ABNORMAL 1118 0.0562
322 BLOOD PRESSURE INCREASED 8590 0.0561
323 HEAD INJURY 1771 0.0559
324 NERVE COMPRESSION 516 0.0559
325 APHASIA 1688 0.0558
326 BLOOD CALCIUM INCREASED 488 0.0556
327 OBESITY 885 0.0555
328 SKIN ULCER 1434 0.0554
329 HYPERCALCAEMIA 684 0.0553
330 DYSURIA 2037 0.0553
331 PLASMA CELL MYELOMA 2157 0.0552
332 NEUROPATHY PERIPHERAL 5253 0.0552
333 SPINAL COMPRESSION FRACTURE 456 0.0551
334 HEPATIC STEATOSIS 1026 0.0550
335 RESPIRATORY RATE INCREASED 488 0.0549
336 HYPOKALAEMIA 2525 0.0547
337 RESPIRATORY TRACT CONGESTION 868 0.0546
338 UPPER-AIRWAY COUGH SYNDROME 449 0.0544
339 SWOLLEN TONGUE 1702 0.0544
340 PAROSMIA 411 0.0544
341 POLLAKIURIA 2271 0.0544
342 OXYGEN SATURATION DECREASED 3059 0.0544
343 THROMBOSIS 4371 0.0543
344 MULTI-ORGAN FAILURE 939 0.0543
345 OCULAR DISCOMFORT 609 0.0542
346 PETECHIAE 566 0.0542
347 HYPOXIA 1909 0.0542
348 ORAL CANDIDIASIS 713 0.0541
349 INFUSION SITE PAIN 697 0.0540
350 SPUTUM DISCOLOURED 513 0.0540
351 CELLULITIS 2718 0.0539
352 RETINAL HAEMORRHAGE 384 0.0539
353 LIMB INJURY 1464 0.0538
354 HYPERTENSION 11414 0.0538
355 ASTHENIA 20260 0.0538
356 HYPOPHAGIA 1376 0.0538
357 DRUG INTERACTION 8522 0.0537
358 BLADDER DISORDER 533 0.0536
359 RED BLOOD CELL SEDIMENTATION RATE INCREASED 593 0.0535
360 CHROMATURIA 1208 0.0535
361 UNRESPONSIVE TO STIMULI 1380 0.0534
362 BRONCHITIS 3957 0.0534
363 URINARY TRACT INFECTION 9110 0.0534
364 HOT FLUSH 4024 0.0533
365 POST PROCEDURAL COMPLICATION 1022 0.0532
366 JOINT INJURY 1136 0.0531
367 HYPERGLYCAEMIA 1937 0.0531
368 RIGHT VENTRICULAR FAILURE 372 0.0530
369 GENERALISED OEDEMA 657 0.0530
370 CHOLELITHIASIS 1740 0.0530
371 INCONTINENCE 560 0.0529
372 PRODUCT ADMINISTRATION INTERRUPTED 415 0.0528
373 PNEUMONIA 17060 0.0526
374 CHEST DISCOMFORT 5384 0.0525
375 GASTROINTESTINAL PAIN 578 0.0525
376 SPLENOMEGALY 615 0.0524
377 ACIDOSIS 401 0.0524
378 PREMATURE DELIVERY 835 0.0524
379 DYSPEPSIA 5158 0.0524
380 CARDIAC DISORDER 4904 0.0524
381 INFARCTION 358 0.0523
382 DEEP VEIN THROMBOSIS 3390 0.0521
383 MIDDLE INSOMNIA 971 0.0519
384 TINNITUS 2386 0.0519
385 HYPOKINESIA 753 0.0518
386 LOCALISED INFECTION 1254 0.0518
387 DYSPNOEA 29348 0.0518
388 FLUID OVERLOAD 753 0.0517
389 INTERVERTEBRAL DISC PROTRUSION 1129 0.0516
390 BACK DISORDER 839 0.0515
391 URINARY INCONTINENCE 1528 0.0515
392 GASTROENTERITIS 752 0.0515
393 LIVER FUNCTION TEST ABNORMAL 1495 0.0514
394 ARTHRITIS 4043 0.0513
395 LYMPHOEDEMA 355 0.0513
396 HICCUPS 421 0.0512
397 WHITE BLOOD CELL COUNT INCREASED 1962 0.0511
398 RENAL IMPAIRMENT 4279 0.0509
399 HIP FRACTURE 1635 0.0508
400 EMBOLISM 422 0.0508
401 CONFUSIONAL STATE 8209 0.0507
402 ANURIA 437 0.0507
403 FLUID RETENTION 2580 0.0507
404 MUSCLE ATROPHY 640 0.0505
405 PULMONARY FIBROSIS 969 0.0505
406 AGEUSIA 1260 0.0505
407 DIPLOPIA 1310 0.0504
408 EATING DISORDER 1073 0.0503
409 SPINAL DISORDER 476 0.0502
410 MUSCULOSKELETAL PAIN 2632 0.0502
411 WEIGHT DECREASED 14021 0.0502
412 MYALGIA 8539 0.0502
413 SECRETION DISCHARGE 629 0.0502
414 ANGIOEDEMA 2220 0.0501
415 COUGH 14073 0.0501
416 DEMENTIA 1402 0.0501
417 TOOTH DISORDER 1114 0.0500
418 METABOLIC ACIDOSIS 1600 0.0500
419 TRANSFUSION 524 0.0500
420 BONE DISORDER 910 0.0499
421 DECREASED ACTIVITY 538 0.0498
422 HYPOCALCAEMIA 943 0.0498
423 COGNITIVE DISORDER 2322 0.0497
424 HOSPICE CARE 491 0.0497
425 PELVIC FRACTURE 386 0.0495
426 POLYURIA 405 0.0494
427 URINARY RETENTION 1647 0.0493
428 MALNUTRITION 552 0.0493
429 LABORATORY TEST ABNORMAL 1450 0.0491
430 DIZZINESS 24482 0.0490
431 DIABETES MELLITUS 3740 0.0490
432 HEAD DISCOMFORT 866 0.0489
433 LACTIC ACIDOSIS 1584 0.0489
434 PARAESTHESIA ORAL 705 0.0488
435 BACK PAIN 11326 0.0487
436 ERUCTATION 943 0.0487
437 ARRHYTHMIA 2302 0.0486
438 PARAESTHESIA 7638 0.0485
439 DYSPHONIA 2830 0.0483
440 BLOOD GLUCOSE FLUCTUATION 530 0.0483
441 MUSCLE SPASMS 8868 0.0483
442 RESPIRATORY FAILURE 3524 0.0483
443 PERIPHERAL SWELLING 7441 0.0483
444 RESTLESS LEGS SYNDROME 878 0.0482
445 PANCREATITIS ACUTE 1083 0.0481
446 BOWEL MOVEMENT IRREGULARITY 369 0.0481
447 SINUS TACHYCARDIA 684 0.0481
448 DYSSTASIA 1405 0.0481
449 ANAL INCONTINENCE 432 0.0480
450 MUSCLE SPASTICITY 590 0.0480
451 WEIGHT FLUCTUATION 502 0.0479
452 PULMONARY THROMBOSIS 523 0.0479
453 NECK PAIN 2672 0.0478
454 SQUAMOUS CELL CARCINOMA 450 0.0478
455 JOINT DISLOCATION 504 0.0476
456 FACIAL PAIN 425 0.0476
457 ATAXIA 564 0.0475
458 SENSATION OF FOREIGN BODY 400 0.0474
459 WOUND INFECTION 519 0.0473
460 RHINORRHOEA 3059 0.0473
461 TACHYPNOEA 643 0.0472
462 HYDRONEPHROSIS 354 0.0472
463 UPPER RESPIRATORY TRACT INFECTION 2181 0.0472
464 MASS 659 0.0471
465 COLD SWEAT 830 0.0470
466 DISORIENTATION 1866 0.0470
467 HEART RATE INCREASED 4642 0.0468
468 PAIN IN EXTREMITY 13793 0.0468
469 PRURITUS GENERALISED 1012 0.0468
470 FLATULENCE 2653 0.0467
471 ORAL PAIN 1046 0.0467
472 PHARYNGITIS 579 0.0466
473 GALLBLADDER DISORDER 830 0.0465
474 SMALL INTESTINAL OBSTRUCTION 572 0.0464
475 DECREASED APPETITE 10780 0.0464
476 CARDIAC ARREST 3829 0.0463
477 HERNIA 896 0.0463
478 TOOTH FRACTURE 510 0.0462
479 NIGHT SWEATS 1486 0.0461
480 HYPERTENSIVE CRISIS 513 0.0461
481 PURPURA 408 0.0461
482 GAIT DISTURBANCE 8819 0.0460
483 DEPRESSED LEVEL OF CONSCIOUSNESS 1821 0.0460
484 HALLUCINATION, VISUAL 971 0.0459
485 ESCHERICHIA INFECTION 378 0.0459
486 COVID-19 PNEUMONIA 542 0.0459
487 OSTEOPOROSIS 1881 0.0457
488 EYE PAIN 2579 0.0457
489 LIMB DISCOMFORT 1412 0.0456
490 FEELING COLD 1269 0.0455
491 PALPITATIONS 5335 0.0455
492 GLAUCOMA 877 0.0455
493 SEPSIS 5078 0.0455
494 DYSPHAGIA 4315 0.0454
495 HYPERSOMNIA 1302 0.0454
496 FOOT FRACTURE 861 0.0454
497 LETHARGY 2612 0.0454
498 ERECTILE DYSFUNCTION 1165 0.0453
499 PALLOR 1234 0.0453
500 IMPAIRED GASTRIC EMPTYING 618 0.0453
501 DRUG TOXICITY 617 0.0453
502 GLYCOSYLATED HAEMOGLOBIN INCREASED 1142 0.0452
503 MOBILITY DECREASED 3251 0.0452
504 PHOTOPHOBIA 850 0.0451
505 BACK INJURY 491 0.0451
506 TOOTH INFECTION 595 0.0451
507 NEUTROPHIL COUNT INCREASED 461 0.0450
508 OSTEOMYELITIS 815 0.0450
509 HYPERHIDROSIS 5798 0.0450
510 HYPOTHYROIDISM 1436 0.0449
511 PNEUMONIA ASPIRATION 1121 0.0448
512 LOSS OF CONSCIOUSNESS 5733 0.0447
513 FATIGUE 34761 0.0446
514 FREQUENT BOWEL MOVEMENTS 1206 0.0446
515 DIARRHOEA 28776 0.0445
516 TOOTHACHE 806 0.0445
517 TOOTH ABSCESS 453 0.0444
518 ABASIA 1098 0.0444
519 THYROID DISORDER 685 0.0444
520 RENAL DISORDER 2070 0.0444
521 CARDIOVASCULAR DISORDER 1126 0.0443
522 HALLUCINATION 3335 0.0442
523 ABNORMAL FAECES 362 0.0441
524 BLINDNESS UNILATERAL 623 0.0441
525 NEPHROLITHIASIS 2024 0.0441
526 ALANINE AMINOTRANSFERASE INCREASED 2709 0.0441
527 LIP SWELLING 1468 0.0440
528 PAIN IN JAW 1248 0.0440
529 BLOOD GLUCOSE DECREASED 2115 0.0440
530 DEAFNESS 1149 0.0439
531 SKIN DISCOLOURATION 2015 0.0438
532 MUSCLE DISORDER 355 0.0438
533 INITIAL INSOMNIA 448 0.0436
534 CHOLECYSTITIS 520 0.0436
535 PLATELET COUNT DECREASED 4651 0.0436
536 DIARRHOEA HAEMORRHAGIC 407 0.0435
537 BURNING SENSATION 3049 0.0434
538 DRY MOUTH 3521 0.0434
539 ANKLE FRACTURE 671 0.0433
540 SINUSITIS 4440 0.0433
541 DELIRIUM 1502 0.0432
542 NASAL CONGESTION 2543 0.0432
543 ABDOMINAL DISCOMFORT 7253 0.0432
544 PULMONARY EMBOLISM 4108 0.0432
545 VERTIGO 2631 0.0431
546 SNEEZING 968 0.0431
547 WHITE BLOOD CELL COUNT DECREASED 4667 0.0430
548 WRIST FRACTURE 516 0.0430
549 HYPOAESTHESIA 6439 0.0430
550 LIGAMENT SPRAIN 425 0.0429
551 PNEUMONIA BACTERIAL 394 0.0429
552 POOR QUALITY SLEEP 924 0.0429
553 C-REACTIVE PROTEIN INCREASED 1560 0.0428
554 ABDOMINAL PAIN UPPER 8814 0.0428
555 CHOKING 834 0.0427
556 AMNESIA 2781 0.0427
557 FACIAL PARALYSIS 364 0.0427
558 EYE INFECTION 482 0.0426
559 DERMATITIS CONTACT 486 0.0426
560 TASTE DISORDER 860 0.0423
561 NERVE INJURY 471 0.0423
562 TENDON RUPTURE 522 0.0422
563 PHARYNGEAL OEDEMA 650 0.0422
564 ASPARTATE AMINOTRANSFERASE INCREASED 2244 0.0422
565 ASPIRATION 462 0.0421
566 DELUSION 654 0.0421
567 FEELING JITTERY 800 0.0419
568 RENAL PAIN 444 0.0418
569 BLOOD GLUCOSE INCREASED 7888 0.0418
570 RETCHING 890 0.0417
571 ARTHROPATHY 2320 0.0417
572 PNEUMOTHORAX 660 0.0416
573 THROMBOCYTOPENIA 4644 0.0415
574 SPINAL FRACTURE 832 0.0415
575 CARDIO-RESPIRATORY ARREST 1736 0.0415
576 BLOOD LACTATE DEHYDROGENASE INCREASED 657 0.0414
577 CONTRAINDICATED PRODUCT ADMINISTERED 1251 0.0413
578 ALTERED STATE OF CONSCIOUSNESS 895 0.0413
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1971 0.0410
580 GENERAL PHYSICAL HEALTH DETERIORATION 4735 0.0409
581 EAR DISCOMFORT 419 0.0408
582 JOINT RANGE OF MOTION DECREASED 547 0.0407
583 GASTRIC DISORDER 1399 0.0407
584 DIALYSIS 578 0.0407
585 GASTROENTERITIS VIRAL 735 0.0407
586 CHILLS 4767 0.0406
587 STAPHYLOCOCCAL INFECTION 1339 0.0406
588 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 689 0.0405
589 TACHYCARDIA 3603 0.0405
590 SUDDEN DEATH 428 0.0404
591 BLOOD COUNT ABNORMAL 612 0.0403
592 DRY THROAT 410 0.0403
593 EAR PAIN 783 0.0402
594 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 413 0.0402
595 ACTIVITIES OF DAILY LIVING IMPAIRED 795 0.0401
596 CLOSTRIDIUM DIFFICILE INFECTION 876 0.0401
597 SPEECH DISORDER 2102 0.0401
598 THROAT IRRITATION 1799 0.0401
599 VITREOUS FLOATERS 394 0.0400
600 TOXIC EPIDERMAL NECROLYSIS 608 0.0400
601 IMPAIRED HEALING 1314 0.0400
602 DYSGEUSIA 2973 0.0400
603 AFFECT LABILITY 385 0.0400
604 RASH PRURITIC 2168 0.0400
605 SKIN LESION 1097 0.0400
606 JAUNDICE 1076 0.0399
607 TENDONITIS 619 0.0399
608 ABDOMINAL DISTENSION 4172 0.0399
609 TEMPERATURE INTOLERANCE 412 0.0399
610 UPPER LIMB FRACTURE 792 0.0397
611 FEEDING DISORDER 806 0.0397
612 PRESCRIBED UNDERDOSE 791 0.0396
613 NEURALGIA 964 0.0396
614 INSOMNIA 10559 0.0396
615 CYST 492 0.0396
616 COLITIS 1501 0.0396
617 GAMMA-GLUTAMYLTRANSFERASE INCREASED 877 0.0395
618 RESPIRATORY DISTRESS 1091 0.0395
619 MUSCLE TIGHTNESS 640 0.0395
620 HEPATOMEGALY 388 0.0394
621 SHOCK 907 0.0394
622 THERAPEUTIC RESPONSE UNEXPECTED 1769 0.0394
623 ASTHMA 4448 0.0393
624 HAIR COLOUR CHANGES 489 0.0393
625 FOOT DEFORMITY 435 0.0392
626 PREMATURE BABY 1180 0.0392
627 ANHEDONIA 1030 0.0392
628 DENTAL CARIES 432 0.0390
629 MALIGNANT MELANOMA 522 0.0389
630 ABDOMINAL PAIN 8997 0.0386
631 HERPES ZOSTER 2222 0.0386
632 VISION BLURRED 5301 0.0386
633 EAR INFECTION 1026 0.0385
634 TREMOR 6392 0.0385
635 BLOOD TEST ABNORMAL 541 0.0385
636 BONE PAIN 2255 0.0385
637 VISUAL ACUITY REDUCED 1277 0.0384
638 RASH MACULAR 1336 0.0382
639 SWELLING FACE 2486 0.0381
640 ASCITES 1120 0.0381
641 LACRIMATION INCREASED 1148 0.0380
642 SEPTIC SHOCK 1651 0.0379
643 PRURITUS 14554 0.0378
644 SLUGGISHNESS 386 0.0378
645 MEMORY IMPAIRMENT 5199 0.0378
646 BACTERAEMIA 449 0.0378
647 KNEE ARTHROPLASTY 796 0.0378
648 PULMONARY ARTERIAL HYPERTENSION 547 0.0377
649 PARKINSONISM 367 0.0376
650 BODY TEMPERATURE INCREASED 765 0.0375
651 NERVOUSNESS 1957 0.0374
652 SEDATION 980 0.0374
653 SENSORY DISTURBANCE 600 0.0373
654 VIRAL INFECTION 1242 0.0373
655 HAIR TEXTURE ABNORMAL 497 0.0371
656 VOMITING 17468 0.0371
657 EOSINOPHILIA 651 0.0371
658 MOVEMENT DISORDER 1192 0.0371
659 NAUSEA 29362 0.0371
660 HIP ARTHROPLASTY 568 0.0370
661 OROPHARYNGEAL PAIN 3421 0.0369
662 BLOOD BILIRUBIN INCREASED 997 0.0369
663 ARTHRALGIA 15326 0.0368
664 JOINT SWELLING 4447 0.0368
665 SCRATCH 388 0.0367
666 BRONCHOSPASM 524 0.0367
667 MUSCULOSKELETAL DISORDER 696 0.0365
668 POLYNEUROPATHY 437 0.0365
669 KIDNEY INFECTION 715 0.0364
670 ENCEPHALOPATHY 893 0.0363
671 WOUND 1015 0.0363
672 MUSCLE TWITCHING 836 0.0362
673 DEPRESSION 8237 0.0362
674 PANCREATITIS 1913 0.0362
675 PROTEINURIA 688 0.0362
676 SCAR 619 0.0361
677 NASOPHARYNGITIS 6658 0.0361
678 SKIN CANCER 777 0.0361
679 INFLUENZA 4022 0.0360
680 PANCYTOPENIA 2014 0.0360
681 FIBROMYALGIA 876 0.0360
682 GAIT INABILITY 1201 0.0359
683 SOMNOLENCE 7233 0.0359
684 HYPOACUSIS 1542 0.0358
685 SCAB 408 0.0357
686 BACTERIAL INFECTION 667 0.0357
687 EYE DISORDER 1173 0.0356
688 HEADACHE 22284 0.0355
689 BRAIN FOG 557 0.0355
690 RASH GENERALISED 920 0.0355
691 NO THERAPEUTIC RESPONSE 433 0.0355
692 RESTLESSNESS 1297 0.0354
693 LUNG DISORDER 1734 0.0353
694 MYOCLONUS 421 0.0353
695 TREATMENT NONCOMPLIANCE 1928 0.0352
696 CYANOSIS 553 0.0351
697 DRUG ERUPTION 621 0.0350
698 SLEEP DISORDER 2472 0.0350
699 CANDIDA INFECTION 589 0.0348
700 LOCAL SWELLING 607 0.0348
701 PRODUCT USE IN UNAPPROVED INDICATION 8604 0.0347
702 HEPATIC CIRRHOSIS 651 0.0346
703 FEELING ABNORMAL 8298 0.0346
704 IRRITABLE BOWEL SYNDROME 742 0.0346
705 INCORRECT DRUG ADMINISTRATION DURATION 973 0.0346
706 BLOOD GLUCOSE ABNORMAL 638 0.0345
707 JOINT STIFFNESS 904 0.0344
708 LOWER LIMB FRACTURE 662 0.0344
709 BLINDNESS 1399 0.0343
710 NODULE 447 0.0342
711 SPINAL PAIN 400 0.0341
712 ABDOMINAL PAIN LOWER 862 0.0341
713 MEDICATION ERROR 1893 0.0340
714 ILEUS 423 0.0340
715 COLON CANCER 507 0.0340
716 LIVER DISORDER 1501 0.0338
717 IMPAIRED QUALITY OF LIFE 486 0.0338
718 FEAR 908 0.0337
719 ORAL DISCOMFORT 469 0.0337
720 ANXIETY 9597 0.0337
721 DYSKINESIA 1370 0.0337
722 ABNORMAL DREAMS 930 0.0336
723 PYREXIA 11653 0.0336
724 NIGHTMARE 1163 0.0336
725 STOMATITIS 2036 0.0335
726 HYPOAESTHESIA ORAL 506 0.0335
727 FEMUR FRACTURE 1039 0.0335
728 WEIGHT INCREASED 7507 0.0335
729 MUSCULOSKELETAL STIFFNESS 2936 0.0335
730 MALAISE 14686 0.0335
731 PNEUMONITIS 910 0.0334
732 RESPIRATORY DISORDER 999 0.0334
733 HEPATIC ENZYME INCREASED 2272 0.0333
734 LYMPHOCYTE COUNT DECREASED 589 0.0333
735 MOUTH ULCERATION 701 0.0332
736 BLISTER 1867 0.0332
737 COVID-19 5829 0.0332
738 CHOLECYSTECTOMY 379 0.0331
739 DISSEMINATED INTRAVASCULAR COAGULATION 465 0.0330
740 DIABETIC KETOACIDOSIS 791 0.0329
741 BEDRIDDEN 432 0.0328
742 SKIN INFECTION 368 0.0328
743 EYE SWELLING 1219 0.0327
744 LOWER RESPIRATORY TRACT INFECTION 1489 0.0327
745 ELECTROCARDIOGRAM QT PROLONGED 1177 0.0327
746 PAIN 20049 0.0326
747 HYPERTHYROIDISM 471 0.0325
748 ANAPHYLACTIC REACTION 1795 0.0325
749 INJURY 2278 0.0324
750 CONVULSION 1852 0.0324
751 PERICARDITIS 544 0.0323
752 GASTROINTESTINAL DISORDER 2899 0.0323
753 ROAD TRAFFIC ACCIDENT 1353 0.0323
754 DEPRESSED MOOD 1707 0.0323
755 IMPAIRED DRIVING ABILITY 367 0.0323
756 SKIN DISORDER 1076 0.0322
757 ERYTHEMA 6626 0.0322
758 BRAIN OEDEMA 407 0.0322
759 PHOTOSENSITIVITY REACTION 532 0.0322
760 HEPATITIS 815 0.0318
761 MYELODYSPLASTIC SYNDROME 460 0.0318
762 ADRENAL INSUFFICIENCY 385 0.0317
763 APHONIA 442 0.0316
764 COMA 1504 0.0316
765 DRUG ADMINISTRATION ERROR 965 0.0314
766 STEVENS-JOHNSON SYNDROME 697 0.0313
767 EYELID OEDEMA 364 0.0313
768 MADAROSIS 363 0.0312
769 IMPAIRED WORK ABILITY 668 0.0312
770 INSURANCE ISSUE 477 0.0312
771 PRODUCT PRESCRIBING ERROR 743 0.0312
772 THIRST 557 0.0311
773 THROAT TIGHTNESS 841 0.0311
774 NEUTROPHIL COUNT DECREASED 1266 0.0310
775 UNEVALUABLE EVENT 2346 0.0310
776 INFLUENZA LIKE ILLNESS 2552 0.0310
777 DRUG LEVEL INCREASED 513 0.0310
778 SWELLING 2899 0.0309
779 DISTURBANCE IN ATTENTION 1668 0.0309
780 AGITATION 2270 0.0309
781 LUNG INFECTION 480 0.0309
782 RASH PAPULAR 692 0.0308
783 PARALYSIS 440 0.0307
784 VISUAL IMPAIRMENT 3804 0.0307
785 THERAPY CESSATION 1574 0.0306
786 DEVICE OCCLUSION 431 0.0306
787 MIGRAINE 2923 0.0306
788 DRUG-INDUCED LIVER INJURY 960 0.0306
789 ACUTE RESPIRATORY DISTRESS SYNDROME 540 0.0305
790 IMMUNE SYSTEM DISORDER 402 0.0305
791 RASH 13266 0.0304
792 CONDITION AGGRAVATED 9197 0.0302
793 PRODUCT ADMINISTRATION ERROR 610 0.0302
794 SYNOVITIS 544 0.0301
795 PARANOIA 520 0.0301
796 PHARMACEUTICAL PRODUCT COMPLAINT 782 0.0301
797 LEUKOPENIA 1505 0.0301
798 RASH ERYTHEMATOUS 1437 0.0300
799 QUALITY OF LIFE DECREASED 402 0.0299
800 LYMPHADENOPATHY 1060 0.0299
801 MULTIPLE ORGAN DYSFUNCTION SYNDROME 847 0.0299
802 THERAPY NON-RESPONDER 1343 0.0298
803 INTESTINAL OBSTRUCTION 1123 0.0298
804 PROCEDURAL PAIN 819 0.0295
805 DRUG INTOLERANCE 2844 0.0294
806 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1069 0.0294
807 INTENTIONAL PRODUCT USE ISSUE 2574 0.0294
808 DRY EYE 1466 0.0293
809 FUNGAL INFECTION 977 0.0293
810 INFECTION 4242 0.0293
811 INTRAOCULAR PRESSURE INCREASED 374 0.0292
812 THINKING ABNORMAL 541 0.0290
813 TOOTH EXTRACTION 358 0.0287
814 DISEASE RECURRENCE 1362 0.0286
815 SARS-COV-2 TEST POSITIVE 378 0.0286
816 LIVER FUNCTION TEST INCREASED 612 0.0285
817 LIVER INJURY 696 0.0283
818 HEPATIC FAILURE 854 0.0283
819 PRESCRIBED OVERDOSE 548 0.0283
820 ILLNESS 2897 0.0281
821 APATHY 410 0.0281
822 IMMUNODEFICIENCY 419 0.0281
823 URTICARIA 4687 0.0279
824 NEUTROPENIA 3803 0.0279
825 CONJUNCTIVITIS 518 0.0279
826 INJECTION SITE BRUISING 2223 0.0278
827 DISCOMFORT 1699 0.0278
828 ANOSMIA 403 0.0278
829 INJECTION SITE HAEMATOMA 403 0.0277
830 FEBRILE NEUTROPENIA 1838 0.0277
831 DEVICE RELATED INFECTION 426 0.0276
832 THERAPY INTERRUPTED 1971 0.0276
833 RASH MACULO-PAPULAR 613 0.0275
834 OCULAR HYPERAEMIA 1307 0.0275
835 MENTAL IMPAIRMENT 667 0.0275
836 ABSCESS 438 0.0274
837 GLOSSODYNIA 614 0.0274
838 INCREASED APPETITE 524 0.0274
839 ACCIDENTAL OVERDOSE 1003 0.0274
840 PRODUCT DOSE OMISSION IN ERROR 769 0.0271
841 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1927 0.0271
842 INTENTIONAL PRODUCT MISUSE 2367 0.0270
843 INFLAMMATION 1387 0.0268
844 HEPATIC FUNCTION ABNORMAL 1000 0.0268
845 PRODUCT USE ISSUE 5025 0.0267
846 INTENTIONAL DOSE OMISSION 760 0.0266
847 ACUTE HEPATIC FAILURE 364 0.0266
848 FACE OEDEMA 449 0.0266
849 MULTIPLE FRACTURES 435 0.0265
850 PERITONITIS 548 0.0264
851 TRANSAMINASES INCREASED 588 0.0264
852 INJECTION SITE HAEMORRHAGE 2112 0.0264
853 DRUG EFFECT LESS THAN EXPECTED 389 0.0262
854 EYE IRRITATION 1505 0.0261
855 METASTASES TO BONE 429 0.0261
856 COLITIS ULCERATIVE 1167 0.0261
857 SKIN EXFOLIATION 2196 0.0260
858 RHEUMATOID ARTHRITIS 2954 0.0260
859 INFUSION RELATED REACTION 1721 0.0259
860 PANIC ATTACK 946 0.0259
861 PRODUCT USE COMPLAINT 408 0.0259
862 SKIN BURNING SENSATION 1838 0.0256
863 HUNGER 356 0.0255
864 INTERSTITIAL LUNG DISEASE 1234 0.0255
865 INTENTIONAL DRUG MISUSE 532 0.0254
866 DRUG PRESCRIBING ERROR 488 0.0254
867 HYPERSENSITIVITY 4674 0.0252
868 ADVERSE DRUG REACTION 2260 0.0251
869 CHOLESTASIS 478 0.0249
870 FRACTURE 471 0.0249
871 DISEASE PROGRESSION 2942 0.0248
872 METASTASES TO LIVER 436 0.0248
873 MENTAL DISORDER 1078 0.0247
874 DRUG DOSE OMISSION 4080 0.0247
875 HALLUCINATION, AUDITORY 392 0.0246
876 EXPIRED PRODUCT ADMINISTERED 812 0.0244
877 EYE PRURITUS 817 0.0243
878 FOETAL EXPOSURE DURING PREGNANCY 1975 0.0243
879 DERMATITIS 508 0.0242
880 PRODUCT AVAILABILITY ISSUE 551 0.0242
881 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1327 0.0242
882 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1719 0.0241
883 LUNG NEOPLASM MALIGNANT 993 0.0241
884 SKIN FISSURES 472 0.0241
885 OFF LABEL USE 21108 0.0241
886 RESPIRATORY ARREST 664 0.0241
887 NERVOUS SYSTEM DISORDER 751 0.0240
888 EXPOSURE DURING PREGNANCY 1490 0.0239
889 SURGERY 1397 0.0238
890 DRUG EFFECT DECREASED 1279 0.0237
891 AGRANULOCYTOSIS 440 0.0236
892 ORAL HERPES 462 0.0236
893 OSTEONECROSIS OF JAW 579 0.0234
894 HEPATOTOXICITY 520 0.0233
895 PRODUCT DOSE OMISSION 1509 0.0231
896 PRODUCT DOSE OMISSION ISSUE 6794 0.0231
897 ECZEMA 1201 0.0229
898 UNDERDOSE 1668 0.0228
899 SEROTONIN SYNDROME 438 0.0228
900 PSORIASIS 2952 0.0226
901 PRODUCT PHYSICAL ISSUE 455 0.0225
902 MUCOSAL INFLAMMATION 590 0.0225
903 ANAPHYLACTIC SHOCK 580 0.0225
904 MATERNAL EXPOSURE DURING PREGNANCY 2000 0.0224
905 PSYCHOMOTOR HYPERACTIVITY 370 0.0223
906 ALOPECIA 4370 0.0222
907 PRODUCT QUALITY ISSUE 3008 0.0221
908 SEIZURE 2549 0.0220
909 ABNORMAL BEHAVIOUR 866 0.0218
910 DRY SKIN 2917 0.0218
911 ILL-DEFINED DISORDER 1327 0.0218
912 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 503 0.0216
913 PSORIATIC ARTHROPATHY 873 0.0215
914 AGGRESSION 1076 0.0215
915 SYSTEMIC LUPUS ERYTHEMATOSUS 760 0.0214
916 PRODUCT PRESCRIBING ISSUE 465 0.0213
917 MULTIPLE SCLEROSIS 1015 0.0212
918 EMOTIONAL DISORDER 653 0.0212
919 PAIN OF SKIN 570 0.0211
920 DRUG INEFFECTIVE 27603 0.0209
921 ANGER 704 0.0208
922 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3741 0.0207
923 DRUG EFFECT INCOMPLETE 749 0.0206
924 THERAPEUTIC PRODUCT EFFECT DECREASED 921 0.0205
925 DRUG RESISTANCE 528 0.0205
926 PSYCHOTIC DISORDER 603 0.0204
927 INCORRECT PRODUCT ADMINISTRATION DURATION 442 0.0204
928 INCORRECT DOSE ADMINISTERED 4645 0.0203
929 IRRITABILITY 1219 0.0203
930 DISABILITY 400 0.0202
931 CRYING 734 0.0202
932 INJECTION SITE MASS 741 0.0200
933 BONE MARROW FAILURE 404 0.0199
934 TOXICITY TO VARIOUS AGENTS 3333 0.0197
935 THERAPEUTIC RESPONSE DECREASED 1189 0.0196
936 HOSPITALISATION 2975 0.0193
937 ADVERSE EVENT 1780 0.0193
938 OSTEONECROSIS 632 0.0192
939 INTENTIONAL OVERDOSE 1226 0.0191
940 PRODUCT SUBSTITUTION ISSUE 1096 0.0190
941 VAGINAL HAEMORRHAGE 822 0.0189
942 TOOTH LOSS 392 0.0189
943 MOOD ALTERED 511 0.0187
944 DEATH 16000 0.0186
945 BONE DENSITY DECREASED 581 0.0185
946 EPILEPSY 557 0.0182
947 EMOTIONAL DISTRESS 2200 0.0182
948 MALIGNANT NEOPLASM PROGRESSION 1792 0.0175
949 MULTIPLE SCLEROSIS RELAPSE 1195 0.0174
950 MOOD SWINGS 552 0.0173
951 SUICIDAL IDEATION 1585 0.0173
952 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 430 0.0167
953 THERAPEUTIC RESPONSE SHORTENED 538 0.0162
954 NEOPLASM PROGRESSION 562 0.0161
955 SUICIDE ATTEMPT 974 0.0160
956 NEOPLASM MALIGNANT 1070 0.0160
957 APPLICATION SITE ERYTHEMA 416 0.0159
958 OVERDOSE 3391 0.0157
959 EXTRA DOSE ADMINISTERED 626 0.0154
960 PANCREATIC CARCINOMA 440 0.0152
961 NEEDLE ISSUE 439 0.0151
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3016 0.0149
963 EXTRAPYRAMIDAL DISORDER 359 0.0144
964 INJECTION SITE PAIN 4383 0.0143
965 INJECTION SITE PRURITUS 954 0.0142
966 DEVICE MALFUNCTION 992 0.0141
967 INJECTION SITE ERYTHEMA 1736 0.0140
968 WITHDRAWAL SYNDROME 575 0.0137
969 TARDIVE DYSKINESIA 363 0.0129
970 DEVICE DISLOCATION 559 0.0128
971 INJECTION SITE RASH 393 0.0128
972 DEVICE ISSUE 1132 0.0126
973 ABORTION SPONTANEOUS 498 0.0124
974 PROSTATE CANCER 992 0.0123
975 DRUG EXPOSURE DURING PREGNANCY 415 0.0122
976 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 411 0.0122
977 COMPLETED SUICIDE 967 0.0116
978 INJECTION SITE SWELLING 885 0.0115
979 TREATMENT FAILURE 937 0.0113
980 SKIN IRRITATION 508 0.0111
981 BREAST CANCER 973 0.0104
982 INJECTION SITE REACTION 696 0.0101
983 DEVICE LEAKAGE 437 0.0101
984 ACNE 757 0.0100
985 DERMATITIS ATOPIC 449 0.0085
986 DRUG WITHDRAWAL SYNDROME 697 0.0079
987 BLADDER CANCER 464 0.0079
988 DRUG ABUSE 609 0.0073
989 NO ADVERSE EVENT 1322 0.0073
990 DEVICE DIFFICULT TO USE 439 0.0066
991 ACCIDENTAL EXPOSURE TO PRODUCT 628 0.0061
992 DRUG DEPENDENCE 972 0.0060
993 PRODUCT STORAGE ERROR 516 0.0059
994 DRUG DOSE OMISSION BY DEVICE 367 0.0047